Suchergebnisse - "Bosman, Brigitte"

PubPharm (16)

1

Relationship between mean volume voided and incontinence in children with overactive bladder treated with solifenacin : post hoc analysis of a phase 3 randomised clinical trial

enthalten in: European journal of pediatrics | 2020

von Snijder, R. | Bosman, B. | Stroosma, O. | +1

2

Long-term efficacy and safety of solifenacin in pediatric patients aged 6 months to 18 years with neurogenic detrusor overactivity : results from two phase 3 prospective open-label studies

enthalten in: Journal of pediatric urology | 2020

von Franco, I. | Hoebeke, P. | Baka-Ostrowska, M. | +9

3

Relationship between mean volume voided and incontinence in children with overactive bladder treated with solifenacin: post hoc analysis of a phase 3 randomised clinical trial

enthalten in: European journal of pediatrics | 2020

von Snijder, R. | Bosman, B. | Stroosma, O. | +1

4

Relationship between mean volume voided and incontinence in children with overactive bladder treated with solifenacin: post hoc analysis of a phase 3 randomised clinical trial

enthalten in: European journal of pediatrics | 2020

von Snijder, R. | Bosman, B. | Stroosma, O. | +1

5

Relationship between mean volume voided and incontinence in children with overactive bladder treated with solifenacin: post hoc analysis of a phase 3 randomised clinical trial

enthalten in: European journal of pediatrics | 2020

von Snijder, R. | Bosman, B. | Stroosma, O. | +1

6

The pharmacokinetics, safety, and tolerability of mirabegron in children and adolescents with neurogenic detrusor overactivity or idiopathic overactive bladder and development of a population pharmacokinetic model-based pediatric dose estimation

enthalten in: Journal of pediatric urology | 2020

von Rittig, S. | Baka-Ostrowska, M. | Tøndel, C. | +6

7

Long-Term Safety and Efficacy of Solifenacin in Children and Adolescents with Overactive Bladder

enthalten in: The Journal of urology | 2017

von Newgreen, D. | Bosman, B. | Hollestein-Havelaar, A. | +6

CommentIn: J Urol. 2017 Oct;198(4):936. - PMID 28727983

8

Solifenacin in Children and Adolescents with Overactive Bladder : Results of a Phase 3 Randomised Clinical Trial

enthalten in: European urology | 2017

von Newgreen, D. | Bosman, B. | Hollestein-Havelaar, A. | +5

9

Solifenacin in Children and Adolescents with Overactive Bladder: Results of a Phase 3 Randomised Clinical Trial

enthalten in: European urology | 2017

von Newgreen, D. | Bosman, B. | Hollestein-Havelaar, A. | +5

10

COMBINED USE OF AN ALPHA-ADRENERGIC RECEPTOR ANTAGONIST AND AN ANTI-MUSCARINIC AGENT

enthalten in: Europäisches Patentamt | 2016

von VAN CHARLDORP KARIN JULIETTE | BOSMAN BRIGITTE JOHANNA FANNY | KLAVER MONIQUE MARIA ALIDA | +2